Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Taysha Gene Therapies (TSHA) Return on Assets (2022 - 2025)

Historic Return on Assets for Taysha Gene Therapies (TSHA) over the last 4 years, with Q3 2025 value amounting to 0.29%.

  • Taysha Gene Therapies' Return on Assets rose 1400.0% to 0.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.29%, marking a year-over-year increase of 1400.0%. This contributed to the annual value of 0.51% for FY2024, which is 100.0% down from last year.
  • Taysha Gene Therapies' Return on Assets amounted to 0.29% in Q3 2025, which was up 1400.0% from 0.37% recorded in Q2 2025.
  • In the past 5 years, Taysha Gene Therapies' Return on Assets ranged from a high of 0.29% in Q3 2025 and a low of 1.4% during Q4 2022
  • For the 4-year period, Taysha Gene Therapies' Return on Assets averaged around 0.68%, with its median value being 0.49% (2024).
  • Its Return on Assets has fluctuated over the past 5 years, first soared by 10000bps in 2023, then tumbled by -1000bps in 2024.
  • Quarter analysis of 4 years shows Taysha Gene Therapies' Return on Assets stood at 1.4% in 2022, then surged by 71bps to 0.4% in 2023, then fell by -24bps to 0.5% in 2024, then surged by 42bps to 0.29% in 2025.
  • Its last three reported values are 0.29% in Q3 2025, 0.37% for Q2 2025, and 0.55% during Q1 2025.